Table 5 Quality of Evidence
Author, Year | Study Design | EPHPP Global Quality Assessment Rating |
|---|---|---|
Hess, 2007 [21] | Non-Randomized Feasibility | Weak |
Hess, 2007 [21] | Non-Randomized Feasibility | Weak |
Wilson, 2008 [27] | Cluster Randomized Control Trial | Weak |
Holt, 2010 [51] | 2 group Pretest-Posttest | Weak |
Johnson, 2010 [20] | 2 group Pretest-Posttest | Weak |
Luque, 2011 [53] | 1 group Posttest only | Weak |
Sadler, 2011 [29] | Cluster Randomized Control Trial | Weak |
Cluster Randomized Control Trial | Strong | |
Odedina, 2014 [52] | 1 group Pretest-Posttest | Weak |
Sadler, 2014 [30] | Cluster Randomized Control Trial | Weak |
Frencher, 2016 [50] | 2 group Pretest-Posttest | Weak |
Cole, 2017 [55] | Randomized Control Trial | Weak |
Victor, 2018 [44] | Cluster Randomized Control Trial | Moderate |
Victor, 2019 [45] | Cluster Randomized Control Trial | Moderate |